EAM Investors’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
VCM
ACH
WA
PCH
EAM Investors's AXGN Position: Q1 2026 in Review
EAM Investors reduced its Axogen (AXGN) stake by 71% in Q1 2026, selling an estimated $3.58M and leaving 45,606 shares worth $1.51M. The position accounts for 0.17% of the portfolio, ranked #185.
EAM Investors first reported a position in AXGN in Q3 2015 and has held it in 19 quarters since. The position peaked at $5.64M in Q3 2017. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.
- EAM Investors held 45,606 shares of Axogen worth $1.51M as of Q1 2026.
- EAM Investors sold 110,192 Axogen shares in Q1 2026, an estimated $3.58M.
- Axogen made up 0.17% of EAM Investors's portfolio in Q1 2026, its #185 holding.
- EAM Investors first reported a position in Axogen in Q3 2015 and has held it in 19 quarters since.
- EAM Investors's Axogen position peaked at $5.64M in Q3 2017.
- 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.
Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.